Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. (DMIIU) is a blank-check company focused on identifying a merger target in the pharmaceutical manufacturing sector, with a particular emphasis on domestic drug production. The "II" designation marks the sponsor's second SPAC vehicle under the Drugs Made In America banner, indicating a repeat management team with prior experience navigating the SPAC lifecycle. The company filed its annual report on Form 10-K with the SEC on April 15, 2026, reflecting its continued search for a qualifying business combination target. As a sector-focused vehicle, DMIIU is positioned to pursue opportunities among U.S.-based pharmaceutical manufacturers and related supply chain companies. Sign up at SpacDesk for full filing history, sponsor track record, and deal timeline data on DMIIU and hundreds of other active SPACs.